MEDIORG — Medicamen Organics Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹365.31m
- IN₹493.80m
- IN₹226.30m
Annual cashflow statement for Medicamen Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.783 | 12.5 | 33.9 | 54.3 | -52.8 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4.07 | 5.46 | 6.34 | 4.19 | 6.83 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.3 | -32.2 | -84 | -110 | -6.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.949 | -6.05 | -36.6 | -45.4 | -46 |
| Capital Expenditures | -6.16 | -2.89 | -3.51 | -24.5 | -17.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.217 | 0.098 | 0.134 | 0.948 | 0.223 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.95 | -2.79 | -3.37 | -23.5 | -17.1 |
| Financing Cash Flow Items | -4.28 | -5.55 | 5.53 | 76.8 | 10.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.33 | 9.99 | 40.1 | 105 | 34.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.56 | 1.14 | 0.149 | 35.8 | -28.3 |